Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Headache- and migraine-inducing effects of pitolisant in women with migraine without aura
2026-525521-20-00Phase 2Authorised
- Sponsor
- University of Southern Denmark
- Start
- Mar 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of pitolisant in migraine without aura (2 arms), sponsored by University of Southern Denmark. Primary endpoint: Occurrence of migraine-like attacks after pitolisant vs placebo. Planned start Mar 2026; status: authorised.
02
Drugs
pitolisant
03
Conditions
migraine without aura
Beyond the preview
Go deeper on 2026-525521-20-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2026-525521-20-00.